Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Regulatory News (SIHL)

Share Price Information for Symphony (SIHL)

Share Price is delayed by 15 minutes
Get Live Data
0.347    -0.001 (-0.29%)
Bid:
0.326
Ask:
0.368
Spread: 0.042 (12.883%)
Market Cap: $178.65m
SIHL Live PriceLast checked at - London Stock Exchange

Intraday Symphony Share Chart

Holding(s) in Company

21 Feb 2013 10:13

RNS Number : 3894Y
Symphony International Holdings Ltd
21 February 2013
 



TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Symphony International Holdings Limited

 

2. Reason for the notification:

 

An acquisition or disposal of voting rights

 

3. Full name of person(s) subject to the notification obligation:

 

British Empire Securities and General Trust plc

 

4. Full name of shareholder(s) (if different from 3.):

 

Chase Nominees Limited (CREST: BT01C Sub a/c No.2)

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

 

19 February 2013

 

6. Date on which issuer notified:

 

19 February 2013

 

7. Threshold(s) that is/are crossed or reached:

 

6%

 

8. Notified details:

 

A: Voting rights attached to shares

 

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction

Number of shares

Number of voting Rights

VGG548121059

Ordinary shares

28,936,503

 

28,936,503

 

Resulting situation after the triggering transaction

 

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

VGG548121059

Ordinary shares

 

35,056,503

 

35,056,503

 

 

 

6.8%

 

0%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% if voting rights

 

N/A

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

N/A

 

Total (A+B+C)

Number of voting rights

% of voting rights

35,056,503

6.8%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable :

 

Chase Nominees Limited is custodian for British Empire Securities and General Trust plc

 

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

 

11. Number of voting rights proxy holder will cease to hold:

 

N/A

 

 

12. Date on which proxy holder will cease to hold voting rights:

 

N/A

 

13. Additional information:

 

N/A

 

14. Contact name:

 

Nicola Sayers, Capita Company Secretarial Services

 

15. Contact telephone number:

 

0207 954 9529

 

21 February 2013

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUGGPUPWGUG
Date   Source Headline
29th Apr 20262:16 pmRNSResult of AGM
28th Jan 202611:52 amRNSKey Information Document
27th Jan 202610:15 amRNSDirector/PDMR Shareholding
27th Jan 202610:12 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSNet Asset Value(s)
4th Nov 202511:16 amRNSResponse to Shareholder Correspondence
17th Sep 20257:00 amRNSNet Asset Value(s)
17th Sep 20257:00 amRNSInterim Financial Results
26th Jun 20257:00 amRNSNet Asset Value(s)
30th Apr 202512:08 pmRNSResult of AGM
4th Apr 20259:50 amRNSAnnual Financial Report
4th Apr 20259:49 amRNSNotice of AGM
4th Apr 20259:46 amRNSNet Asset Value(s)
5th Feb 202510:38 amRNSDirector/PDMR Shareholding
5th Feb 202510:37 amRNSDirector/PDMR Shareholding
17th Jan 20252:54 pmRNSDirector/PDMR Shareholding
16th Dec 202410:12 amRNSNet Asset Value(s)
27th Sep 20247:00 amRNSNet Asset Value(s)
27th Sep 20247:00 amRNSInterim Financial Results
28th Jun 202411:46 amRNSNet Asset Value(s)
28th Jun 202411:46 amRNSUpdate on Reporting
30th Apr 202410:45 amRNSResult of AGM
5th Apr 20247:00 amRNSAnnual Financial Report
5th Apr 20247:00 amRNSNotice of Annual General Meeting
20th Mar 20246:17 pmRNSNet Asset Value(s)
20th Mar 20247:00 amRNSPreliminary Results
20th Mar 20247:00 amRNSShareholder Update
1st Feb 202411:15 amRNSDirector/PDMR Shareholding
1st Feb 202411:14 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 202312:25 pmRNSDirector/PDMR Shareholding
11th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 20237:00 amRNSShareholder Update
16th Nov 20237:00 amRNSKey Information Document
2nd Nov 202311:43 amRNSDirector/PDMR Shareholding
2nd Nov 202311:41 amRNSHolding(s) in Company
1st Nov 20231:27 pmRNSDirector/PDMR Shareholding
1st Nov 20231:26 pmRNSDirector/PDMR Shareholding
26th Oct 202311:15 amRNSDirector/PDMR Shareholding
16th Oct 202311:38 amRNSDirector/PDMR Shareholding
10th Oct 202312:02 pmRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSShareholder Update
26th Sep 20237:00 amRNSInterim Financial Results
25th Sep 202311:27 amRNSStrategy Update
29th Jun 20237:00 amRNSDividend Declaration
19th Jun 20237:00 amRNSNet Asset Value(s)
19th Jun 20237:00 amRNSShareholder Update
15th May 202311:27 amRNSDirector Update
28th Apr 20233:11 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.